<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03152929</url>
  </required_header>
  <id_info>
    <org_study_id>2016-306</org_study_id>
    <nct_id>NCT03152929</nct_id>
  </id_info>
  <brief_title>Paravertebral Block Versus Pectoral Nerve Block</brief_title>
  <official_title>Paravertebral Block Versus Pectoral Nerve Block for Analgesia Following Mastectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spectrum Health Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spectrum Health Hospitals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare two standard methods of pain control management used&#xD;
      at Spectrum Health for patients undergoing breast surgery. The two methods being compared are&#xD;
      the paravertebral block and the pectoral nerve block. Postoperative pain control is essential&#xD;
      following any major operative procedure. A variety of methods have been utilized to ensure&#xD;
      adequate analgesia, each with its own advantages and risks. Increasingly, attention has&#xD;
      focused on regional methods of analgesia, which may allow for reduction in systemic narcotic&#xD;
      use and their associated complications. Proposed benefits of regional analgesia and a&#xD;
      resultant reduction in narcotic use include decreased risk of cancer progression, decreased&#xD;
      length of stay, and decreased risk of ileus.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to compare the clinical profiles of two currently acceptable&#xD;
      analgesia techniques. The most common regional block used to achieve postoperative analgesia&#xD;
      following mastectomy is the paravertebral block, during which local anesthetic is injected&#xD;
      into the paravertebral space which contains the thoracic spinal nerves, between the&#xD;
      costotransverse ligament and the pleura. At our institution there has been recent interest in&#xD;
      an alternative regional block. The pectoral nerve block is performed by injecting anesthetic&#xD;
      between the pectoralis major and the pectoralis minor (PECs I) or between the pectoralis&#xD;
      minor and the serratus anterior (PEC II).&#xD;
&#xD;
      The proposed advantage of the pectoral nerve block for regional anesthesia during breast&#xD;
      surgery is equal analgesic efficacy with fewer potential complications.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 20, 2016</start_date>
  <completion_date type="Anticipated">February 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative Narcotic Use</measure>
    <time_frame>First 24 hours post-PACU (or until discharge)</time_frame>
    <description>Narcotics used for pain during surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post Anesthesia Care Unit (PACU) narcotic use</measure>
    <time_frame>First 24 hours post-PACU (or until discharge)</time_frame>
    <description>Narcotics used in PACU</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative narcotic use</measure>
    <time_frame>First 24 hours post-PACU (or until discharge)</time_frame>
    <description>Narcotics used postoperatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain control measured by length of operating</measure>
    <time_frame>2 weeks postoperative</time_frame>
    <description>Measuring pain control by how long (in minutes) patient is in surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain control measured by estimated blood loss</measure>
    <time_frame>2 weeks postoperative</time_frame>
    <description>Measuring blood loss (in ml) during surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative nausea</measure>
    <time_frame>2 weeks postoperative</time_frame>
    <description>The presence of nausea after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain control measured by pain scale</measure>
    <time_frame>2 weeks postoperative</time_frame>
    <description>Pain measured on scale of one to ten</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain control measured by the use of pain pills postoperatively</measure>
    <time_frame>2 weeks postoperative</time_frame>
    <description>Number of pain pills needed postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain control measured by calls to physicians office relating to pain</measure>
    <time_frame>2 weeks postoperative</time_frame>
    <description>The number of calls made to the physicians office due to pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Paravertebral Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Paravertebral Block is performed along the spine utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pectoral Nerve Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Pectoral Nerve Block is performed anteriorly, at the level of the axillary line, also utilizing ultrasound guided technique (20-30 mL 0.5% Ropivacaine)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paravertebral Block</intervention_name>
    <description>20-30 mL 0.5% Ropivacaine</description>
    <arm_group_label>Paravertebral Block</arm_group_label>
    <other_name>PVB</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pectoral Nerve Block</intervention_name>
    <description>20-30 mL 0.5% Ropivacaine</description>
    <arm_group_label>Pectoral Nerve Block</arm_group_label>
    <other_name>PEC</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female patients â‰¥ 18 years of age&#xD;
&#xD;
          -  Total mastectomy or partial mastectomy with or without reconstruction OR planned&#xD;
             lumpectomy.&#xD;
&#xD;
          -  Patient determined by their surgeon as medically able to receive a regional block for&#xD;
             post-operative analgesia&#xD;
&#xD;
          -  Patient agrees to participate in the study and signs informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Neoadjuvent radiation therapy&#xD;
&#xD;
          -  Stage IV cancer&#xD;
&#xD;
          -  Previous breast surgery (excluding percutaneous biopsies of all types)&#xD;
&#xD;
          -  History of either PVB or PEC procedures&#xD;
&#xD;
          -  Planned general anesthesia use during surgery&#xD;
&#xD;
          -  Allergies to ropivacaine, midazolam, fentanyl, or propofol&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Prisoners&#xD;
&#xD;
          -  Adults unable to consent&#xD;
&#xD;
          -  Non-English-speaking patients&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marianne Melink, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spectrum Health Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Spectrum Health</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Travis Krautwurst, BS</last_name>
      <phone>616-391-2724</phone>
      <email>travis.krautwurst@spectrumhealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>March 1, 2017</study_first_submitted>
  <study_first_submitted_qc>May 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2017</study_first_posted>
  <last_update_submitted>May 11, 2017</last_update_submitted>
  <last_update_submitted_qc>May 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Surgery</keyword>
  <keyword>Breast</keyword>
  <keyword>Pectoral Never Block</keyword>
  <keyword>Paravertebral Block</keyword>
  <keyword>Analgesia</keyword>
  <keyword>Mastectomy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

